| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |